ArticleAnnals of surgical treatment and research2023

Can chemotherapy be omitted for patients with N0 or N1 endocrine-sensitive breast cancer treated with gonadotropin-releasing hormone agonist and tamoxifen?

Juhyeon Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.